SANTEN PHARMACEUTICAL CO financial statements, including revenue, expenses, profit, and loss

The total revenue of 4536 for the last quarter is 77.03 B JPY, and it's 4.92% higher compared to the previous quarter. The net income of Q3 23 is 7.33 B JPY.